{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:02:30Z","timestamp":1781244150880,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Foundation Against Cancer (FCC\/STK)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.lungcan.2018.10.009","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T17:21:06Z","timestamp":1539105666000},"page":"258-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Real-life treatment practice for malignant pleural mesothelioma in Belgium"],"prefix":"10.1016","volume":"125","author":[{"given":"Michael","family":"Rosskamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Macq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiaan","family":"Nackaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbet","family":"Van Eycken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlinde","family":"De Schutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"April (2)","key":"10.1016\/j.lungcan.2018.10.009_bib0005","first-page":"162","article-title":"Latency periods in asbestos-related mesothelioma of the pleura","volume":"6","author":"Bianchi","year":"1997","journal-title":"Eur. J. Cancer Prev."},{"issue":"March5","key":"10.1016\/j.lungcan.2018.10.009_bib0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/sj.bjc.6601638","article-title":"The mesothelioma epidemic in Western Europe: an update","volume":"90","author":"Pelucchi","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"April2","key":"10.1016\/j.lungcan.2018.10.009_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1179\/2049396714Y.0000000058","article-title":"Asbestos in Belgium: an underestimated health risk. The evolution of mesothelioma mortality rates (1969\u20132009)","volume":"20","author":"Van den Borre","year":"2014","journal-title":"Int. J. Occup. Environ. Health"},{"issue":"2","key":"10.1016\/j.lungcan.2018.10.009_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: the standard of care and challenges for future management","volume":"78","author":"Van Meerbeeck","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"14","key":"10.1016\/j.lungcan.2018.10.009_bib0025","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0030","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"26","author":"Van Meerbeeck","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"Suppl. 5","key":"10.1016\/j.lungcan.2018.10.009_bib0040","doi-asserted-by":"crossref","first-page":"v31","DOI":"10.1093\/annonc\/mdv199","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Baas","year":"2015","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.10.009_bib0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lungcan.2015.05.014","article-title":"Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England","volume":"89","author":"Damhuis","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.10.009_bib0050","series-title":"Cancer Burden in Belgium 2004-2013, Belgian Cancer Registry, Brussels","year":"2015"},{"key":"10.1016\/j.lungcan.2018.10.009_bib0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lungcan.2018.05.018","article-title":"Assessing the completeness and correctness of the registration of malignant mesothelioma in Belgium","volume":"122","author":"Rosskamp","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.10.009_bib0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-8140(03)00229-9","article-title":"Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey","volume":"68","author":"De Ruysscher","year":"2003","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0065","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology \u2013 Norwegian Institute of Public Health: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0070","series-title":"Cancer Survival in Belgium, Belgian Cancer Registry, Brussels","year":"2012"},{"key":"10.1016\/j.lungcan.2018.10.009_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2307\/2530286","article-title":"A confidence interval for the median survival time","volume":"38","author":"Brookmeyer","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.lungcan.2018.10.009_bib0080","article-title":"Statistical methods for cancer survival analysis","volume":"vol. 2","author":"Swaminathan","year":"2011"},{"key":"10.1016\/j.lungcan.2018.10.009_bib0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.lungcan.2018.10.009_bib0090","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus non extra-pleural pneumonectomy for patients with malignant pleural Mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0095","first-page":"298","article-title":"Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy","volume":"40","author":"Sugarbaker","year":"2011","journal-title":"Eur. J. Cardiol. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0100","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","article-title":"Trimodality therapy for malignant pleural mesothelioma: results from a EORTC phase II multicentre trial","volume":"36","author":"Van Schil","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0105","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jtcvs.2007.02.014","article-title":"Ten traps for the unwary in surgical series: a case study in mesothelioma reports","volume":"133","author":"Treasure","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.lungcan.2018.10.009_bib0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.21037\/atm.2016.03.17","article-title":"Perspective on malignant pleural mesothelioma diagnosis and treatment","volume":"4","author":"Wald","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"11","key":"10.1016\/j.lungcan.2018.10.009_bib0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.21037\/atm.2017.04.05","article-title":"Randomized controlled trials in malignant pleural mesothelioma surgery-mistakes made and lessons learned","volume":"5","author":"Waller","year":"2017","journal-title":"Ann. Transl. Med."},{"issue":"29","key":"10.1016\/j.lungcan.2018.10.009_bib0120","first-page":"3354","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.10.009_bib0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000486578","article-title":"Mangement and survival of pleural mesothelioma: a record linkage study","volume":"95","author":"Carioli","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.lungcan.2018.10.009_bib0130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.athoracsur.2017.09.036","article-title":"National trends in the epidemiology of malignant pleural mesothelioma: a national cancer data base study","volume":"105","author":"Saddoughi","year":"2018","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lungcan.2017.08.009","article-title":"Patterns of care and survival among patients with malignant mesothelioma in the United States","volume":"112","author":"Enewold","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.10.009_bib0140","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.2147\/OTT.S100214","article-title":"The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma","volume":"9","author":"Azzouqa","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.lungcan.2018.10.009_bib0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.17554\/j.issn.2412-2424.2016.02.22","article-title":"Biological and clinical aspects of malignant pleural mesothelioma: past, present and future treatment strategies","volume":"2","author":"Colaut","year":"2016","journal-title":"J. Respir. Res."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0150","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1183\/16000617.0063-2016","article-title":"Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment","volume":"25","author":"Bibby","year":"2016","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0155","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00319-2017","article-title":"Malignant pleural mesothelioma: new treatments, new hopes?","volume":"49","author":"Scherpereel","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.lungcan.2018.10.009_bib0160","first-page":"197","article-title":"Current management of malignant pleural mesothelioma","volume":"8","author":"Hiddinga","year":"2014","journal-title":"Belg. J. Med. Oncol."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0165","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Meosthelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomized, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"issue":"September (9)","key":"10.1016\/j.lungcan.2018.10.009_bib0170","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(17)30446-1","article-title":"Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Maio","year":"2017","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.10.009_bib0175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1532-5415.1999.tb01603.x","article-title":"Assessment and control for confounding by indication in observational studies","volume":"47","author":"Psaty","year":"1999","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0180","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomized, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0185","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2016.08.071","article-title":"Extended pleurectomy-decortication-based treatment for advanced stage epithelial mesothelioma yielding a median survival of nearly three years","volume":"103","author":"Friedberg","year":"2017","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0190","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0195","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1470-2045(16)30095-X","article-title":"Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicenter, open-label, phase 3, randomized controlled trial","volume":"17","author":"Clive","year":"2016","journal-title":"Lancet Oncol."},{"issue":"18","key":"10.1016\/j.lungcan.2018.10.009_bib0200","doi-asserted-by":"crossref","first-page":"16766","DOI":"10.18632\/oncotarget.4414","article-title":"Distinctive clinical characteristics of malignant mesothelioma in young patients","volume":"6","author":"Thomas","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.lungcan.2018.10.009_bib0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/thx.2007.085241","article-title":"EGFT and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors","volume":"63","author":"Kothmaier","year":"2008","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.lungcan.2018.10.009_bib0210","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/his.13392","article-title":"The epithelioid BAP1-negative and p16-positive phenotype predicts prolonged survival in pleural mesothelioma","volume":"72","author":"Chou","year":"2018","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.lungcan.2018.10.009_bib0215","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00919-2017","article-title":"Exhaled breath to screen for malignant pleural mesothelioma: a validation study","volume":"50","author":"Lamote","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2018.10.009_bib0220","unstructured":"Van Meerbeeck J.P., Tournoy K., Lievens Y., Remmelink M., Nackaerts K., Nafteux P., et al., Malignant pleural mesothelioma \u2013 preferred model of care and criteria for reference centres. KCE Report 2019 Addendum."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218305932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218305932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T01:30:59Z","timestamp":1540517459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218305932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":44,"alternative-id":["S0169500218305932"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.10.009","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life treatment practice for malignant pleural mesothelioma in Belgium","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}